Apellis Pharmaceuticals's total assets for Q1 2025 were $807.28M, a decrease of -8.79% from the previous quarter. APLS total liabilities were $643.07M for the fiscal quarter, a -2.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.